Insights

Market Reach Novartis Italia operates within a global pharmaceutical framework with products available in 155 countries, suggesting strong distribution networks and potential for cross-border partnerships, regional expansions, and centralized procurement opportunities in healthcare systems.

Innovation Focus The company emphasizes scientific innovation to develop treatments and extend lives, indicating receptiveness to partnerships around novel therapies, gene therapy, and specialty pharmaceuticals that leverage advanced research capabilities.

Digital Backbone Adoption of SAP FICO, IBM Cognos Analytics, Databricks, Power BI, and other enterprise tools points to a data-driven sales approach; there is opportunity to offer analytics, forecasting, and CRM integrations to streamline commercial operations and market analytics.

Talent & Scale With a large global workforce and emphasis on attracting and retaining talent, there is potential to provide solutions around HR technology, workforce analytics, training platforms, and vendor-managed services to support regional teams.

Financial Footprint Revenue range indicates mid-market to enterprise-level opportunities; consider value-based partnerships, pricing models, and scalable service offerings aligned with high-value pharmaceutical customers and multi-country tenders.

Novartis Italia Tech Stack

Novartis Italia uses 8 technology products and services including SAP FICO, IBM Cognos Analytics, Databricks, and more. Explore Novartis Italia's tech stack below.

Novartis Italia's Email Address Formats

Novartis Italia uses at least 4 email formats:
Novartis Italia Email FormatsExamplePercentage
First.Last@novartis.comJohn.Doe@novartis.com
89%
F.Last@novartis.comJ.Doe@novartis.com
5%
FiLast@novartis.comJoDoe@novartis.com
3%
FLast@novartis.comJDoe@novartis.com
3%

Frequently Asked Questions

What is Novartis Italia's official website and social media links?

Minus sign iconPlus sign icon
Novartis Italia's official website is novartis.it and has social profiles on LinkedIn.

How much revenue does Novartis Italia generate?

Minus sign iconPlus sign icon
As of October 2026, Novartis Italia's annual revenue is estimated to be $10M - $25M.

What is Novartis Italia's SIC code and NAICS code?

Minus sign iconPlus sign icon
Novartis Italia's SIC code is 2834 - Pharmaceutical Preparations and NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Novartis Italia have currently?

Minus sign iconPlus sign icon
As of October 2026, Novartis Italia has approximately 578 employees across 4 continents, including Europe, Asia and North America. Key team members include Chief Digital Officer: F. G., Head Of Innovative Partnerships & Solutions: N. A. and Head Of Ee: M. A. Explore Novartis Italia's employee directory with LeadIQ.

What industry does Novartis Italia belong to?

Minus sign iconPlus sign icon
Novartis Italia operates in the Pharmaceutical Manufacturing industry.

What technology does Novartis Italia use?

Minus sign iconPlus sign icon
Novartis Italia's tech stack includes SAP FICO, IBM Cognos Analytics, Databricks, Power BI, Microsoft SharePoint, ADP, Atlassian Jira and Microsoft Sentinel.

What is Novartis Italia's email format?

Minus sign iconPlus sign icon
Novartis Italia's email format typically follows the pattern of First.Last@novartis.com. Find more Novartis Italia email formats with LeadIQ.

When was Novartis Italia founded?

Minus sign iconPlus sign icon
Novartis Italia was founded in 1996.
Novartis Italia logo

Novartis Italia

Pharmaceutical ManufacturingLombardy, Italy501-1000 Employees

Novartis Italia is a pharmaceutical manufacturing company based in Milan, Lombardy. It operates as part of the Novartis Group, which focuses on discovering and developing innovative treatments to improve and extend people’s lives through scientific advances. The group is headquartered in Basel, Switzerland and has a substantial global footprint, with products available in many countries and a large workforce. The Italian unit serves patients and healthcare providers by delivering therapies that address unmet medical needs and support better health outcomes. A notable development in recent years is the 2021 acquisition of Gyroscope Therapeutics to bolster the group's gene therapy capabilities.

Section iconCompany Overview

SIC Code
2834 - Pharmaceutical Preparations
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
1996
Employees
501-1000

Section iconFunding & Financials

  • $10M - $25M

    Novartis Italia's revenue is estimated to be in the range of $10M - $25M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.